View Cart  

Supplements Lead to More Burdens Than Standard Filings, Tufts Finds

A A
NDA and BLA supplements have created more headaches for pharma companies than standard new drug or biologic applications, finds a new study from the Tufts Center for the Study of Drug Development.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00